Table of Content


Introduction
Adrenocortical Carcinoma - Overview
Adrenocortical Carcinoma - Therapeutics Development
Adrenocortical Carcinoma - Therapeutics Assessment
Adrenocortical Carcinoma - Companies Involved in Therapeutics Development
Adrenocortical Carcinoma - Drug Profiles
Adrenocortical Carcinoma - Dormant Projects
Adrenocortical Carcinoma - Discontinued Products
Adrenocortical Carcinoma - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Adrenocortical Carcinoma (Adrenal Cortex Cancer), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Adrenocortical Carcinoma (Adrenal Cortex Cancer), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by Bristol-Myers Squibb Co, H2 2020
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by Corcept Therapeutics Inc, H2 2020
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by Enterome Bioscience SA, H2 2020
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by Exelixis Inc, H2 2020
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by GlaxoSmithKline Plc, H2 2020
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by Infinity Pharmaceuticals Inc, H2 2020
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by Merck & Co Inc, H2 2020
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by Merck KGaA, H2 2020
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by Millendo Therapeutics Inc, H2 2020
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by Orphagen Pharmaceuticals Inc, H2 2020
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by Seneca Therapeutics Inc, H2 2020
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by Y-mAbs Therapeutics Inc, H2 2020
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Dormant Projects, H2 2020
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Discontinued Products, H2 2020